The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
ACCPL Key Metrics
ACCPL Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
ACCPL Share Price
ACCPL
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
ACCPL Stock Analysis
Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median
Negative
Low dividend yield
Neutral
Not enough talking point with neutral stance
Stock in ESM list
The stock has been places in Enhanced Surveillance Measure (ESM) list (ESM - I (34)).
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.158659.
Snapshot
See detailed analysis
ACCPL Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
ACCPL Bulk, Block & Insider Trades
ACCPL Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
No capital change events found
Company Profile
Accretion Pharmaceuticals Limited is an India-based company. The Company is mainly engaged in the business of manufacture, process, trade, sale, purchase, import, export, assemble, distribute, formulate, develop, consult, test and deal in all kinds of drugs, pharmaceutical products and related produ... Read More
Key personnel
Mr. Harshad Nanubhai RathodD
Executive Chairman of the Board, Chief Financial Officer
Ms. Bhavika Dhaval Makadia
Company Secretary, Compliance Officer
Mr. Vivek Ashok Kuma PatelD
Managing Director, Executive Director
Mr. Hardik Mukundbhai PrajapatiD
Executive Director
Mr. Mayur Popatlal SojitraD
Executive Director
Mr. Vijay Bharatbhai AnadkatD
Non-Executive Independent Director
Mr. Shaym Bhadresh KapadiaD
Non-Executive Independent Director
Ms. Grishma Ajayrao ShewaleD
Non-Executive Independent Women Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Accretion Pharmaceuticals Ltd.?
The current share price of Accretion Pharmaceuticals Ltd. is ₹ 77.35 as of 09 Jan 2026.
What is the PE ratio of Accretion Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Accretion Pharmaceuticals Ltd. is 12.66 as of the latest financial data.
What is the ROE and ROCE of Accretion Pharmaceuticals Ltd.?
Accretion Pharmaceuticals Ltd. has a Return on Equity (ROE) of 65.85% and a Return on Capital Employed (ROCE) of 46.07% as per the latest financial reports.
What is the market cap of Accretion Pharmaceuticals Ltd.?
The market capitalization of Accretion Pharmaceuticals Ltd. stands at ₹ 85.98 Cr.
What is the dividend yield of Accretion Pharmaceuticals Ltd.?
The dividend yield of Accretion Pharmaceuticals Ltd. is 0.00% based on the current market price.
What is the RSI of Accretion Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Accretion Pharmaceuticals Ltd. is 38.08.
What is the FII and DII holding in Accretion Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 1.16% and Domestic Institutional Investors (DII) hold 0.00% of Accretion Pharmaceuticals Ltd. shares.
What sector does Accretion Pharmaceuticals Ltd. belong to?
Accretion Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Accretion Pharmaceuticals Ltd. stock?
The beta of Accretion Pharmaceuticals Ltd. stock is -, indicating its volatility relative to the broader market.
